Beta Bionics Reports Third-Quarter Results, Updates 2026 Guidance
Beta Bionics reported results for the quarter ended September 30, 2026, and updated its full-year 2026 guidance.
Story updates
08:04:54 PM UTC
SquawkNews
BETA BIONICS INC Q3 INCOME FROM OPERATIONS USD -26.609 MILLION VS. IBES ESTIMATE USD -26.4 MILLION
08:04:54 PM UTC
SquawkNews
Beta Bionics 3Q Sales $35.5M >BBNX
08:04:54 PM UTC
SquawkNews
Beta Bionics 3Q Loss/Shr 52c >BBNX
IRVINE, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. NASDAQ:BBNX, a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended September 30, 2026 and updated its full year guidance for the year ending De…